1st International China Biopharmaceutical Symposium (ICBPS)

Vaccines, Antibodies and Gene Therapeutics

"development, regulatory approval, production, distribution - China and

Worldwide"

7 to 12 December 2006

Beijing, China

 

The First Announcement and Call for Papers:

 

Meeting Objective: Introduce the medium and smaller sized Western biotech firms and the regulatory communities, the Drug Regulators, to the Chinese Biopharmaceutical Industries. Learn each others’ capabilities and capacities for product development and manufacturing. Learn the technical, scientific, medical and legal aspects of the processes associated with research and development, drug discovery; and developing and bringing biopharmaceuticals and pharmaceuticals to market in China and in the West. These areas include standards, trade practices, case studies, and regulation, as well as distribution/networking, market development internal to and external from China for Chinese and non-Chinese product, bulk product, and an exploration of the benefits of stable supplies of APIs. Of particular emphasis will be papers and presentations from professionals who are in the regulatory agencies of each producing country or who are very familiar with the regulatory process and procedures from each region such as the US and the Americas, the EU, Middle East, Pacific Rim and Asian countries. Contributions of papers and posters from each area are solicited.

 

A. Who Should Attend?:

B. Call for papers/topic and theme areas:

C.  Important Dates:

D.  Important Numbers:

E.  Pre-registration and information:

F. Abstract and Paper Submission:

G. The ICBPS Update e-mail network:

H.  The ICBPS Web-Sites:

I.  Venue:

J. Hosts and Major Sponsors, Sponsors and Co-Sponsors:

K. Registration, Hotel and Accompanied Person Fees: in US $

L. Registration Form Completion:

M. Sponsors:

 

A. Who Should Attend:

          Industry, government and academic professionals in science, medicine, law and policy. Specialists in intellectual property rights, marketing professionals, and government specialists in the requirements area of FDA type organizations in the US, EU, Middle East, Asia and Pacific Rim.  Medical, veterinary, public health and research professionals, industry scientists and engineers with an interest in either introducing product into China, helping to develop specialized product within China or importing product such as API from China are encouraged to participate in this first meeting in China. 

 

B. Call for papers/topic and theme areas:

First and foremost this is a science meeting to exchange ideas and approaches for manufacturing and testing biotherapeutics in both China and Western countries. This exchange may be best accomplished between industries and science, medical, legal and business professionals. Chinese and Western industries have much to gain from each other beyond scientific exchange: China has capabilities and capacities to produce both intermediates and final drug chemicals and biologicals and Western companies have knowledge and ability to test and produce drugs and biologicals according to the GLP/GMP standards required by most countries.

 

Major Topic Areas

Biopharmaceuticals and therapeutics, including vaccines, antibodies and immunomodulation therapeutics. The focus is on new approaches and treatments for old and emerging diseases.

Transitioning from science to products; drug discovery to clinical testing. The road is neither smooth nor straightforward. What are acceptable paths? Case studies are especially important.

Pre-clinical testing and clinical trials. What makes testing and trials successful? Can trials in China and other countries be acceptable to each other without complete duplication?

Production, importance of requirements and procedures for GMP, especially for bulk active pharmaceutical ingredients (APIs). Stability, storage and purity of APIs. How to design a biopharmaceutical plant to meet GMP requirements and why they are important.

How to navigate and understand the regulatory environment -- in different countries.

The role of IP protection and rights in the drug and biotherapeutics industry.

 

Note: Papers should cover any one or a combination of the listed topic areas as well as areas not listed.  For ‘non-listed’ areas, the author could show how the subject does fit with the theme of the Symposium.

Note: Because of the importance of the subject area to all countries, the ICBPS will accept applicants who wish to attend without a paper. Of high importance for the Congress would be those professionals who are active across the areas as mentioned in Paragraph A at the beginning of this First Announcement/Call for papers.

 

C.  Important Dates:

14 April: Pre-registration and/or Registration begins.

10 October: Last date for Abstract submission

30 September: Registration with increased fees

14 November: Program is finalized and sent to the Printer for Publication.

15 November: Completed Papers are due.

07 December: The ICBPS Registration and Welcome Party

 

D.  Important Numbers:

For the ASA/ICBPS team:

Tel: 808-235-8010 and Fax: 808-432-9670

E-mail: info@icbps.org or cbmts@asanltr.com

Web Address: www.icbps.org 

Note for all: On all message traffic, please term “ICBPS” in Subject line. 

 

E.  Pre-registration and information:

Please forward at the earliest time to ASA/ICBPS, your pre-registration information to include name; organization, tel/fax and e-mail numbers, proposed Abstract title. The data requested are also on the ICBPS registration form.

 

F. Abstract and Paper Submission: 

 Abstracts in above Topic Areas are to be 250 words or less and submitted in 

text only format via e-mail to ASA for the Science Review Committee:

Title  (all caps)

Presenting author and organization, address, telephone, fax, and e-mailfirst.  Other authors and organizations after. Only the family name of the presenting author is all caps or upper case.

Body of Abstract: No tables, figures or references are to be used in abstract

File must be named with the family name of the presenting author and must end in NAME_abst.txt. For the example below the file name is:

Price_abst.txt

Abstract submissions are due no later than 10 October.

Completed papers are due no later than 15 November 2006.

• Full information and examples on the Abstract and Paper formats are available at:http://www.icbps.org/abstractinfo.html

 

G. The ICBPS Update e-mail network:

For all prospective participants who would like update information on this ICBPS meeting, please forward your preferred e-mail address for entry into the ICBPS Update network. Send your e-mail address to: cbmts@asanltr.com. To expedite messages, please put “ICBPS” in subject line.

 

H.  The ICBPS Web-Sites:

The official ICBPS web-site is http://www.icbps.org

 

I.  Venue:

 The “ICBPS” will take place at the Crowne Plaza, Hotel Park View Wuzhou, NO. 8 North Si Huan Zhong Road, Beijing, 100101 CHINA

 

J. Hosts and Major Sponsors, Sponsors and Co-Sponsors:

Hosts: The Chinese Pharmaceutical Association (CPA) and the China Biochemical Pharmaceutical Industry Association (CBPIA) in association with Battelle Memorial Institute

Major Sponsors:

The Chinese Pharmaceutical Association (CPA)

The China Biochemical Pharmaceutical Industry Association (CBPIA)

China National Biotec Corporation (CNBC)

Battelle Memorial Institute

US Agency for International Development (see para. M)

Sponsors: 

Acambis, UK/US

Emergent BioSolutions, Gaithersburg, Maryland (see para. M)

Co-Sponsors:

Applied Science and Analysis Inc. (see para. M)

 

K. Registration, Hotel and Accompanied Person Fees: in US $

 NOTE: Individuals may send their registration payment to ASA/ICBPS. Cards to be used include Visa, Master Card, American Express or Check or Electronic Transfer. The special ASA-ICBPS bank account number for bank transfer will be supplied upon request.

 Registration Fees:  Before 30 September = US $850.00

                                 From 30 September = US $950.00

The Registration Fee includes local transportation as well as most meals, the Welcome reception, the Symposium Dinner and several special events as arranged by the hosts. These special events include as a minimum: a tour to the Great Wall, a “Technical Tour” which will be to a biopharmaceutical facility.  Also included are the Coffee Breaks and Conference materials.

 

2. Hotel Fees:  Crowne Plaza  

Room Type	Room Rate
Superior room (Single occupancy)	RMB1125 room/night
Deluxe room (Single occupancy)	RMB1245 room/night
Executive Superior (Single occupancy)	RMB 1425 room/night
Suite room (Single occupancy)	RMB 1725 room/night

All rooms include American buffet breakfast and use of Fitness and Sauna；

Executive and Suite rooms also include free Broadband.

Currently exchange rate: US$ 1 = RMB 7.9

Exchange rate of settlement will be applied to the publicized rate of Bank of China the same day.

IAW information from CPA, please add 80 RMB/day for accompanying person.

Hotels require one night booking fee. This can be held by credit card to ASA/ICBPS who will then guarantee Hotel Booking Fee to The China Commercial International Travel Service, the Travel Agency selected by the ICBPS Organizing Committee to assist with all travel arrangements within China for this meeting.

NOTE: 

Accompanied Person:  US$ 200.00 Registration fee includes: Lunch buffets (4 buffets are planned), Welcome reception, Symposium Dinner,  the Technical tour and the Social tour (Great Wall).  The Accompanied person fees are at less than actual costs but are provided as a courtesy by the ICBPS Organizing Committee. Accompanying persons can book numerous local tours of Beijing from the hotel.

 There will be plenty of time for all accompanied persons to shop at many of the famed shopping centers in and around Beijing.

 This fee is separate from the accompanied person's hotel fee.

 

L. Registration Form Completion:

Registration Forms are to be completed/returned before 30 September 2006.  From 30 September, a late registration fee will be charged.  Payment of fees by credit card (MC, VISA, Amex) or electronic transfer or check by 30 September.  Forms are to be copied and completed and sent by fax or e-mail.

 

NOTE: ASA will forward, upon request, the bank numbers to use for electronic transfer of registration fees and sponsor funding.

Registration Fees include Welcome reception, special Symposium Dinner, a tour to the Great Wall, a Technical Tour; Program and Proceedings, Coffee breaks and Lunches for four days, Congress Bag and supplies

Refund Policy:

Until 1 November - 90% registration fee refunded (10% for bank charge)

From 1 November - 1 December - 75% of registration fee refunded

After 1 December - no refund

 

M. Sponsors:

Sponsors are the only entities permitted to exhibit and conduct business while at the Symposium.  Sponsors are listed in three categories: Major Sponsors, Sponsors and Co-Sponsors

 

Major Sponsors will have up to a double booth space (exhibit set-up) provided at the venue of the Symposium, will have a one page advert provided in the Program and in the Proceedings and in the ASA Newsletter.  Major sponsors will have up to four registrations paid. A major sponsor contribution to the Symposium will be: US $ 14,000.

Sponsors will have a booth space (exhibit set-up) provided at the venue of the Symposium, will have a one page advert provided in the Program and in the Proceedings and in the ASA Newsletter. Sponsors will have up to 3 registrations paid. A Sponsor contribution to the Symposium will be US $ 10,000.

Co-sponsors will have a booth space (exhibit set-up) provided at the venue of the Symposium and will have a one half page advert provided in the Program and in the Proceedings and in the ASA Newsletter. Co-Sponsors will have up to two registrations paid.  A Co-Sponsor contribution to the Symposium will be US $ 6,500.